資料簡介
topogen是一家成立于1991年的診斷公司,專注于提供與拓撲異構(gòu)酶相關(guān)的產(chǎn)品和服務,特別針對藥物開發(fā)和機制研究。公司提供創(chuàng)新的產(chǎn)品與服務,旨在幫助研究人員和藥物開發(fā)者深入理解藥物對DNA的作用機制,并通過提供先進的測試和篩選工具來加速研究進程。topogen的產(chǎn)品線涵蓋了多種試劑盒、DNA修復報告細胞系、DNA載體和裂解目標、拓撲異構(gòu)酶抑制劑、拓撲異構(gòu)酶抗體等,服務于全球的科研機構(gòu)、藥物開發(fā)公司、臨床研究機構(gòu)以及生物技術(shù)公司。
主要產(chǎn)品線及特點
Topo Kits
提供多種與拓撲異構(gòu)酶相關(guān)的試劑盒,用于研究和藥物篩選。
DNA修復報告細胞系
用于藥物發(fā)現(xiàn),特別是那些可能通過影響DNA修復途徑來增強腫瘤細胞殺傷效果的藥物。
拓撲異構(gòu)酶抑制劑
用于研究和藥物開發(fā),特別是在癌癥治療領域。
拓撲異構(gòu)酶抗體
用于科研和臨床診斷,特別是在檢測和研究拓撲異構(gòu)酶相關(guān)疾病方面。
產(chǎn)品優(yōu)勢 topogen的產(chǎn)品以其高質(zhì)量、創(chuàng)新性和專業(yè)性著稱。公司提供獨立驗證、快速服務和價值,以及保護客戶研究成果的保密協(xié)議。topogen還提供Turn-Key合同服務,以篩選新的拓撲異構(gòu)酶藥物,作為經(jīng)驗豐富的合同研究組織,擁有眾多優(yōu)勢。
熱門產(chǎn)品介紹
Human Topoisomerase II Assay Kit(人拓撲異構(gòu)酶II檢測試劑盒)
特點:用于分析拓撲異構(gòu)酶II活性的藥物篩選。
貨號:TG1001-1(100 Assays)。
應用領域:藥物開發(fā),特別是在癌癥治療和抗菌藥物的研發(fā)方面。
Topoisomerase I Assay Kit(拓撲異構(gòu)酶I檢測試劑盒)
特點:用于分析拓撲異構(gòu)酶I活性的藥物篩選。
貨號:TG1015-1(100 Assays)。
應用領域:藥物開發(fā)和機制研究。
E. Coli DNA Gyrase(大腸桿菌DNA旋轉(zhuǎn)酶)
特點:提供高純度和催化活性的DNA旋轉(zhuǎn)酶,用于科研。
貨號:TG2000G-1(100 Units)。
應用領域:基礎和應用研究,特別是在DNA拓撲學和藥物作用機制研究方面。
公司競爭優(yōu)勢
topogen的競爭優(yōu)勢在于其專注于拓撲異構(gòu)酶領域的專業(yè)知識和經(jīng)驗,以及提供從實驗室到客戶的技術(shù)轉(zhuǎn)移平臺。公司還提供質(zhì)量保證,所有產(chǎn)品都經(jīng)過科學家的驗證和認證,確保產(chǎn)品的可靠性和有效性。
客戶人群
topogen的客戶包括全球的科研機構(gòu)、藥物開發(fā)公司、臨床研究機構(gòu)、生物技術(shù)公司,以及可能涉及公共健康和疾病防治研究的政府機構(gòu)和非營利組織。
社會責任與可持續(xù)發(fā)展
topogen通過提供高質(zhì)量的產(chǎn)品和服務,支持全球的科研和藥物開發(fā)工作,從而履行其社會責任。公司致力于通過其產(chǎn)品和服務推進疾病治療和預防的研究,為實現(xiàn)可持續(xù)發(fā)展目標做出貢獻。
熱賣產(chǎn)品
貨號 | 品名 | 規(guī)格 | 價格 |
DR3000 HRHeLa-Sce | HR based Kit in HeLa Requiring I-Sce1 Transfection (50ug DNA) | 50ug | 31600 |
DR3000 HRHeLa-Sce2 | HR based Kit in HeLa Requiring I-Sce1 Transfection (100ug DNA) | 100ug | 35920 |
DR3000 HRHeLa-Sce3 | HR based Kit in HeLa Requiring I-Sce1 Transfection (250ug DNA) | 250ug | 44720 |
DR3000 HRHeLa-CPR | HR based Kit in HeLa Requiring CRISPR Transfection (50ug DNA) | 50ug | 33360 |
DR3000 HRHeLa-CPR2 | HR based Kit in HeLa Requiring CRISPR Transfection (100ug DNA) | 100ug | 37680 |
DR3000 HRHeLa-CPR3 | HR based Kit in HeLa Requiring CRISPR Transfection (250ug DNA) | 250ug | 46320 |
DR3000 HRCN1.4-Sce | HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (50ug DNA) | 50ug | 38640 |
DR3000 HRCN1.4-Sce2 | HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (100ug DNA) | 100ug | 42960 |
DR3000 HRCN1.4-Sce3 | HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (250ug DNA) | 250ug | 51760 |
DR3000 HRSH-Sce | HR in human Neuroblastoma Cells req. I-Sce1 Transfection (50ug DNA) | 50ug | 38640 |
DR3000 HRSH-Sce2 | HR in human Neuroblastoma Cells req. I-Sce1 Transfection (100ug DNA) | 100ug | 42960 |
DR3000 HRSH-Sce3 | HR in human Neuroblastoma Cells req. I-Sce1 Transfection (250ug DNA) | 250ug | 51760 |
DR3000 HR3T3-Sce | HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (50ug DNA) | 50ug | 31600 |
DR3000 HR3T3-Sce2 | HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (100ug DNA) | 100ug | 35920 |
DR3000 HR3T3-Sce3 | HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (250ug DNA) | 250ug | 44720 |
DR3000 Custom-Sce | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) Includes HRHeLa cell line control (50ug DNA) | 50ug | 38640 |
DR3000 Custom-Sce2 | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) Includes HRHeLa cell line control (100ug DNA) | 100ug | 42960 |
DR3000 Custom-Sce3 | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) Includes HRHeLa cell line control (250ug DNA) | 250ug | 51760 |
DR3000A Custom-Sce | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) No HRHeLa cell line control (50ug DNA) | 50ug | 33360 |
DR3000A Custom-Sce2 | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) No HRHeLa cell line control (100ug DNA) | 100ug | 37680 |
DR3000A Custom-Sce3 | Customer makes own cell line hosting HR Reporter (I-Sce Transfectn req.) No HRHeLa cell line control (250ug DNA) | 250ug | 46320 |
DR5001 HNHela-Sce | NHEJ Based HeLa Requires I-Sce1 Transfection (50ug DNA) | 50ug | 31600 |
DR5001 HNHela-Sce2 | NHEJ Based HeLa Requires I-Sce1 Transfection (100ug DNA) | 100ug | 35920 |
DR5001 HNHela-Sce3 | NHEJ Based HeLa Requires I-Sce1 Transfection (250ug DNA) | 250ug | 44720 |
DR5000 HNSH-Sce | NHEJ Based in Human Neuroblastoma Line requires I-Sce1 transfection (50ug DNA) | 50ug | 38640 |
DR5000 HNSH-Sce2 | NHEJ Based in Human Neuroblastoma Line requires I-Sce1 transfection (100ug DNA) | 100ug | 42960 |
DR5000 HNSH-Sce3 | NHEJ Based in Human Neuroblastoma Line requires I-Sce1 transfection (250ug DNA) | 250ug | 51760 |
DR5000 HNCN1.4-Sce | NHEJ Based in Mouse Neuronal CN1.4度ells requires I-Sce1 transfection (50ug DNA) | 50ug | 38640 |
DR5000 HNCN1.4-Sce2 | NHEJ Based in Mouse Neuronal CN1.4度ells requires I-Sce1 transfection (100ug DNA) | 100ug | 42960 |
DR5000 HNCN1.4-Sce3 | NHEJ Based in Mouse Neuronal CN1.4度ells requires I-Sce1 transfection (250ug DNA) | 250ug | 51760 |
DR5000 HN3T3-Sce | NHEJ Based Mouse 3T3 cells Requires I-Sce1 Transfection (50ug DNA) | 50ug | 31600 |
DR5000 HN3T3-Sce2 | NHEJ Based Mouse 3T3 cells Requires I-Sce1 Transfection (100ug DNA) | 100ug | 35920 |
DR5000 HN3T3-Sce3 | NHEJ Based Mouse 3T3 cells Requires I-Sce1 Transfection (250ug DNA) | 250ug | 44720 |
DR5000 Custom-Sce | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) Includes iHNHeLa cell line control (50ug DNA) | 50ug | 43920 |
DR5000 Custom-Sce2 | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) Includes iHNHeLa cell line control (100ug DNA) | 100ug | 48240 |
DR5000 Custom-Sce3 | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) Includes iHNHeLa cell line control (250ug DNA) | 250ug | 57040 |
DR5000A Custom-Sce | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) NO iHNHeLa cell line control (50ug DNA) | 50ug | 33360 |
DR5000A Custom-Sce2 | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) NO iHNHeLa cell line control (100ug DNA) | 100ug | 37680 |
DR5000A Custom-Sce3 | Customer creates cell line hosting NHEJ Reporter (I-Sce Transfectn req.) NO iHNHeLa cell line control (250ug DNA) | 250ug | 46320 |
DR3050-1 | HR Pooled Cell analysis: 50ug DR-HRGFP, 50ug pSce1, 25ug e-GFP | kit | 14320 |
DR3050-2 | HeLa Cell RepHR Pooled Cell analysis: 250ug DR-HRGFP, 250ug pSce1, 25ug e-GFP | kit | 54320 |
DR3050-3 | HR Pooled Cell analysis: 500ug DR-HRGFP, 500ug pSce1, 25ug e-GFP | kit | 79920 |
DR3050-4 | HR Pooled Cell analysis: 1000ug DR-HRGFP, 1000ug pSce1, 25ug e-GFP | kit | 95920 |
DRT5050-1 | Detailed protocols with 50ug of cNHEJ plasmid, 50ug I-Sce1 plasmid, 50ug eGFP transfection control plasmid | kit | 14320 |
DRT5050-2 | Detailed protocols with 250ug of cNHEJ plasmid, 250ug I-Sce1 plasmid, 50ug eGFP transfection control plasmid | kit | 54320 |
DRT5050-3 | Detailed protocols with 500ug of cNHEJ plasmid, 500ug I-Sce1 plasmid, 50ug eGFP transfection control plasmid | kit | 79920 |
DRT5050-4 | Detailed protocols with 1000ug of cNHEJ plasmid, 1000ug I-Sce1 plasmid, 50ug eGFP transfection control plasmid | kit | 95920 |
TG1050-1 | Topoisomerase Type IIa Nuclear Extraction/Assay Kit | 100assays | 6560 |
TG1001-1 | Topoisomerase II Assay Kit (20ug kDNA) | 100assays | 5120 |
作為topogen在中國區(qū)域的經(jīng)銷商,上海起發(fā)將為中國客戶提供全面的topogen產(chǎn)品。歡迎大家隨時聯(lián)系我們?。。?/span>
上海起發(fā)實驗試劑有限公司是進口品牌innovrsrch、Abbiotec、ALZET、sysy、biorelevant、mybiosource、ABBEXA、progen、absoluteantibody、moradec、Spherotech、Worthington......,國產(chǎn)品牌opmbiosciences、elabscience、耐思、碧云天、博奧森、raybiotech、procell、ORIGENE、apexbt、羅恩、奧浦邁、麥克林、成都正能、fn-test、uelandy、天凈沙、杭州博日、君研生物、藍圖生物、科佰迪、華美、UElandy Inc(試劑)......等300多個品牌中國授權(quán)代理,更多請查詢上海起發(fā)實驗試劑有限公司網(wǎng)站。
相關(guān)產(chǎn)品
免責聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權(quán)行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權(quán)等法律責任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。